论文部分内容阅读
本院从1990年始开展肝癌介入性治疗,共做10例,14人次。体会到在县医院开展肝癌介入性治疗的难度较高,疗效较低。其影响肝癌介入性治疗的因素,主要与选择病例的适应症,临床辅助治疗是否及时,病家的经济承受能力,以及操作者技术熟练程度等有关。一、在刚开展肝癌介入性治疗时,我们对中晚期肝癌的病例选择较宽,病人情况较差。如一例弥漫型肝癌,门脉癌栓,且有肝硬化史15年,介入性治疗时严重黄疸,重度腹水,伴肾功能衰竭,术后仅一周死亡。2例弥漫性及4例多发性肝癌,均伴有肺或脑转移病灶,术后疼痛减轻,食欲增加,自觉症状虽有好转,但也仅生存1～3个月。
The hospital began interventional therapy for liver cancer in 1990, with a total of 10 cases and 14 people. It is difficult to realize the interventional treatment of liver cancer in county hospitals and the efficacy is low. The factors affecting the interventional treatment of liver cancer are mainly related to the indication of the selected case, whether the clinical auxiliary treatment is timely, the economic affordability of the patient, and the technical proficiency of the operator. First, in the case of interventional therapy for liver cancer, we have a wide selection of patients with advanced liver cancer, and the patient’s condition is poor. Such as a case of diffuse liver cancer, portal cancer thrombus, and a history of liver cirrhosis for 15 years, severe jaundice during interventional treatment, severe ascites, renal failure, and only one week after death. Two cases of diffuse and 4 cases of multiple hepatocellular carcinoma were associated with lung or brain metastases, postoperative pain relief, increased appetite, and subjective symptoms, although improved, but only survived for 1 to 3 months.